| 排名 | 分析师 | 机构 | 行业 | 年度收益率 | 6个月收益率 | 3个月收益率 | 正收益比例 | 成分股数量 | 历史最大跌幅 | 更新日期 |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 周豫 | 太平洋 | 医药生物 | 39.61% | 45.98% | 27.56% | 20.00% | 23 | -55.62% | 2025-07-22 |
| 2 | 王斌 | 首创证券 | 医药生物 | 39.61% | 43.37% | 25.00% | -3.03% | 19 | -54.62% | 2025-08-01 |
| 3 | 马云涛 | 国元证券 | 医药生物 | 39.60% | 44.45% | 27.43% | -12.00% | 1 | -47.07% | 2025-08-01 |
| 4 | 张林晚 | 上海证券 | 医药生物 | 39.57% | 44.42% | 37.77% | -100.00% | 1 | -18.93% | 2025-07-18 |
| 5 | 华挺 | 财通证券 | 医药生物 | 39.48% | 37.64% | 16.24% | -6.67% | 7 | -50.33% | 2025-08-12 |
| 6 | 张林晚 | 上海证券 | 医药生物 | 39.47% | 44.32% | 37.04% | -100.00% | 1 | -18.93% | 2025-07-17 |
| 7 | 赵海春 | 国金证券 | 医药生物 | 39.45% | 43.35% | 49.77% | -23.08% | 2 | -61.07% | 2025-08-01 |
| 8 | 周豫 | 太平洋 | 医药生物 | 39.39% | 44.89% | 29.32% | 20.00% | 23 | -55.62% | 2025-07-25 |
| 9 | 华挺 | 财通证券 | 医药生物 | 39.37% | 38.83% | 17.71% | -6.67% | 7 | -50.33% | 2025-07-25 |
| 10 | 李安飞 | 广发证券 | 医药生物 | 39.24% | 29.58% | 35.81% | 2.86% | 1 | -56.96% | 2025-05-08 |
| 11 | 韩盟盟 | 平安证券 | 医药生物 | 39.18% | 41.55% | 32.36% | -15.79% | 1 | -40.52% | 2025-07-16 |
| 12 | 韩世通 | 中信证券 | 医药生物 | 39.14% | 41.39% | 29.35% | -8.70% | 6 | -63.25% | 2025-07-23 |
| 13 | 唐寅灏 | 中信证券 | 医药生物 | 39.14% | 36.16% | 21.29% | 60.00% | 12 | -8.47% | 2025-06-20 |
| 14 | 华挺 | 财通证券 | 医药生物 | 39.03% | 38.74% | 16.12% | -6.67% | 7 | -50.33% | 2025-07-17 |
| 15 | 万鹏辉 | 国海证券 | 医药生物 | 39.02% | 38.89% | 21.04% | 100.00% | 5 | 0.00% | 2025-08-01 |
| 16 | 张林晚 | 上海证券 | 医药生物 | 38.99% | 38.86% | 32.21% | -100.00% | 1 | -18.93% | 2025-07-28 |
| 17 | 韩世通 | 中信证券 | 医药生物 | 38.94% | 41.82% | 33.16% | -8.70% | 6 | -63.25% | 2025-07-17 |
| 18 | 周豫 | 太平洋 | 医药生物 | 38.94% | 45.12% | 28.09% | 20.00% | 23 | -55.62% | 2025-07-23 |
| 19 | 仰佳佳 | 申万宏源 | 医药生物 | 38.92% | 47.23% | 38.82% | 16.67% | 1 | -37.64% | 2025-04-30 |
| 20 | 华挺 | 财通证券 | 医药生物 | 38.89% | 37.23% | 14.81% | -6.67% | 7 | -50.33% | 2025-08-08 |